Fundraising Fox

Jason Gehrke

Investor

Entrepreneur-in-Residence at Third Rock Ventures

West Coast

About

Jason Gehrke joined Third Rock Ventures as an Entrepreneur-in-Residence in 2024, focusing on building immunology and genetic medicine companies. He previously held research leadership roles at Beam Therapeutics, including the BEAM-201 program, and holds a PhD in gene editing from Harvard.

Invests in

Biotech

Experience

  1. Third Rock VenturesEntrepreneur in Residencecurrent2024 β€” present
  2. Beam TherapeuticsVP, Immunology, Genetic Disease, and New Opportunities2023 β€” 2024
  3. Beam TherapeuticsSenior Director and Head of Immunology2022 β€” 2023
  4. Beam TherapeuticsDirector and Head of Immunology2021 β€” 2022
  5. Beam Therapeutics Inc.Senior Scientist, Head of New Opportunities2019 β€” 2020
  6. Beam Therapeutics Inc.Scientist and Head of New Opportunities2018 β€” 2020
  7. Beam Therapeutics Inc.Scientist2018 β€” 2019

Education

  1. UCLABS, Molecular
  2. Harvard UniversityDoctor of Philosophy - PhD, Biochemistry and Molecular Biology

Skills & more

ResearchMolecular Biology4Cell CultureData AnalysisBiochemistryPCRScience3Western BlottingCell BiologyStatisticsProtein Purification1

From Jason's professional profile.

Same school

Shared employers

Also worked at Beam Therapeutics1

Colleagues at Third Rock Ventures